Michael Burry’s Biogen BIIB Stock Holding History

Michael Burry’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$3.01M	–	16
2018 Q4	$3.01M	Buy	+10,000	New	+$3.19M	2.91%	14

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Michael Burry's BIIB Position: Q1 2019 in Review

Michael Burry sold out of Biogen (BIIB) in Q1 2019, closing a stake of 10,000 shares — an estimated $3.01M sold.

Michael Burry first reported a position in BIIB in Q4 2018 and held it in 1 quarter. The position peaked at $3.01M in Q4 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Michael Burry reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Michael Burry sold 10,000 Biogen shares in Q1 2019, an estimated $3.01M.
Michael Burry first reported a position in Biogen in Q4 2018 and held it in 1 quarter.
Michael Burry's Biogen position peaked at $3.01M in Q4 2018.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Scion Asset Management's 13F filing for Q1 2019, filed 15 May 2019.